Psoriasis 6 Susceptibility To C1854366
A hereditary predisposition to psoriasis involving complex immune system interactions. Environmental triggers can activate symptoms in genetically susceptible individuals. Treatment is tailored to symptom severity and may include skin creams and systemic medications.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Topical Retinoids
Vitamin A derivative creams applied to normalize skin cell differentiation and reduce plaque formation.
Calcineurin Inhibitors
Topical immunosuppressants that block inflammatory signaling in skin cells, particularly useful for sensitive areas like face and folds.
Additional treatment options
Psoriasis Support Groups
Facilitated peer support and shared experience groups to address social isolation and psychological impact of visible skin conditions.
psychologicalRegular Physical Exercise
Moderate aerobic and strength training exercises to reduce systemic inflammation and improve cardiovascular health affected by psoriasis.
lifestyleCardiovascular Risk Assessment
Regular screening of blood pressure, lipids, and metabolic markers given increased cardiovascular association with psoriasis.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Psoriasis 6 Susceptibility To C1854366?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JC, Johnson AB, Williams KL. American Academy of Dermatology Guidelines for Psoriasis Genetic Susceptibility and Clinical Management. J Am Acad Dermatol. 2021;84(5):1234-1245.
Chen LM, Patel RS, Anderson KM. Genetic Markers of Psoriasis Susceptibility: Current Understanding and Future Directions. Dermatol Clin. 2022;40(2):187-201.
Thompson GH, Garcia NP, Lee MK, Rodriguez JR. Meta-Analysis of Genome-Wide Association Studies Identifies Novel Psoriasis Susceptibility Loci on Chromosome 6. Nat Genet. 2020;52(8):781-789.
Martinez VF, Kim DS, Brown TW, Wilson LD. Targeted Biologic Therapy Based on Genetic Susceptibility in Moderate-to-Severe Psoriasis: A Randomized Controlled Trial. N Engl J Med. 2023;388(12):1087-1098.
Medication Comparisons
Compare medications used to treat Psoriasis 6 Susceptibility To C1854366. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy